Globe Newswire
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS)?
- Did you purchase your shares between March 17, 2021 and May 7, 2024, inclusive?
- Did you lose money in your investment in Marinus Pharmaceuticals, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired... (continue reading...)
MILTON, Del., June 06, 2024 (GLOBE NEWSWIRE) -- Just in time for the official start of summer, Dogfish Head and Dan-O’s Seasoning are giving everyone another reason to fire-up their grills – a limited-edition, collaborative grilling kit with everything needed to host the ultimate backyard barbeque! Complete with beers, seasoning blends and recipes, the Dogfish Head x Dan-O’s grilling kit will be available exclusively at GiveThemBeer.com, beginning Friday, June... (continue reading...)
MILTON, Del., June 06, 2024 (GLOBE NEWSWIRE) -- Just in time for the official start of summer, Dogfish Head and Dan-O’s Seasoning are giving everyone another reason to fire-up their grills – a limited-edition, collaborative grilling kit with everything needed to host the ultimate backyard barbeque! Complete with beers, seasoning blends and recipes, the Dogfish Head x Dan-O’s grilling kit will be available exclusively at GiveThemBeer.com, beginning Friday, June... (continue reading...)
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Hertz Global Holdings, Inc. (NASDAQ: HTZ)?
- Did you purchase your shares between April 27, 2023 and April 24, 2024, inclusive?
- Did you lose money in your investment in Hertz Global Holdings, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the... (continue reading...)
TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Patients taking new weight loss/diabetes drugs such as semaglutide (Wegovy™), and their doctors, need to be aware of the significant risk they pose for sedation or anesthesia, writes anesthesiologist Paul Kempen, M.D., in the summer issue of the Journal of American Physicians and Surgeons. These drugs impede stomach emptying, thus creating a risk of aspiration of stomach contents and resulting pneumonia.
Television... (continue reading...)
More Globe Newswire
View Older Stories-
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
-
Pepper Lunch Announces First Florida Restaurant to Open Soon
-
PruittHealth Again Certified as a Great Place to Work®
-
Three-Segment Collection From Accompolished Author Brings Joy, Adventure, and Fun To Readers
-
Arctic Wolf Wins Best SME Security Solution at 2024 SC Awards Europe
-
533 Students Receive Student Impact Award
-
INVESTOR ALERT: DiCello Levitt LLP Announces the Filings of a Class Action Against Humana Inc. (NYSE: HUM)
-
Mandatory Notification of Trade
-
Alliance Trust PLC - Transaction in Own Shares
-
PPC.io Raises $5M in Seed Funding To Revolutionize PPC Marketing
-
Joint Commission–Accredited Long-Term Care Hospitals Perform Significantly Better on Key Infection Control Measures
-
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
-
B2BinPay v20 Release: Improved Functionality with TRX Staking and Expanded Blockchain Support
-
ChildCare Education Institute Offers No-Cost Online Course on Discovering Life Science with Young Children
-
OFL to TTC: ‘Get a deal now, or expect more than TTC workers on picket lines tomorrow’
-
THE NEWS FORUM - Why aren’t the UN and Egypt building field hospitals across the Rafah border to help wounded Palestinian civilians - especially children?
-
CN Formally Offers Binding Arbitration to TCRC
-
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
-
Vallourec signs a major contract for the supply of tubes and services to Petrobras
-
Transaction in Own Shares
-
Jack’s Basket and Global Down Syndrome Foundation Collaboration To Provide More Resources to Families in the US and Around the World
-
Mortgage Rates Pull Back
-
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
-
Haffner Energy teams up with LanzaJet for “Paris-Vatry SAF”
-
Market update : FOCUS-27 transformation project financing
-
Electrify Expo Shatters Records with Unprecedented Number of Demos and Attendance, Disrupting the Anti-EV Narrative
-
QXO Announces Leadership Team and Board of Directors
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
QXO Completes $1 Billion Equity Investment
-
Sodexo - Disclosure of transactions in own shares carried out on June 3, 2024
-
VINCI acquires a 20% shareholding in the Budapest airport concession company and becomes the platform operator
-
Wawa Officially Breaks Ground on First Store in Ohio
-
Swift Navigation and Locosys Partner to Deliver Unmatched Price-to-Performance in Precise GNSS Positioning for IoT Applications
-
Nexans completes acquisition of La Triveneta Cavi, expanding European reach
-
Mint Eco Car Wash and Detail Center Celebrates Grand Opening of Fifth Location
-
ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all public schools
-
KIC Realty Announces Removal of Cap for KARE – KIC Agent Retirement Equity Plan
-
Purchase of Own Securities and Total Voting Rights
-
Form 8.5 (EPT/RI) - Alpha Financial Markets Consulting plc
-
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
-
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
-
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
-
Oceana and Actor Dennis Haysbert Team Up in New PSA for National Oceans Month
-
Lowey Dannenberg Notifies Fastly, Inc. (“Fastly” or the “Company”) (NYSE: FSLY) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contac
-
Legend Senior Living Assumes Management, Renames Four Florida Properties, Increases Portfolio to 59
-
Director Declaration
-
Legend Senior Living Assumes Management, Renames Four Florida Properties, Increases Portfolio to 59
-
Lowey Dannenberg Notifies Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to
-
Dr. Puneet Dwivedi Receives the SFI Leadership in Conservation Award for Advancing Knowledge and Understanding of the Value of SFI Fiber Sourcing
-
Dr. Puneet Dwivedi Receives the SFI Leadership in Conservation Award for Advancing Knowledge and Understanding of the Value of SFI Fiber Sourcing
